Asymmetrical barcode adapterassisted recovery of duplicate reads and error correction strategy to detect rare mutations in circulating tumor DNA

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Ahn, Jinwoo ^a   Byungjin, Hwang ^a   Kim, Ha Young ^a   Hoon, Jang ^a   Kim, Hwang Phill ^b,c   Han, Sae Won ^b,d   Kim, Tae You ^b,c,d   Lee, Ji Hyun ^e   Bang, Duhee ^a  

^a Yonsei University   (South Korea)

^b Seoul National University   (South Korea)

^c Seoul National University   (South Korea)

^d Seoul National University Hospital   (South Korea)

^e Kyung Hee University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CIRCULATING TUMOR DNA; DNA;

CHEMISTRY; DNA MUTATIONAL ANALYSIS; GENETICS; GENOTYPE; HIGH THROUGHPUT SEQUENCING; HUMAN; MUTATION; NEOPLASM; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

CIRCULATING TUMOR DNA; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; GENOTYPE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MUTATION; NEOPLASMS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 85018731610     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep46678     Document Type: Article

References (26)

1. Sboner, A., Mu, X. J., Greenbaum, D., Auerbach, R. K. & Gerstein, M. B. The real cost of sequencing: higher than you think! Genome biology 12, 125, doi: 10.1186/gb-2011-12-8-125 (2011).
2. Meldrum, C., Doyle, M. A. & Tothill, R. W. Next-generation sequencing for cancer diagnostics: a practical perspective. The Clinical biochemist. Reviews/Australian Association of Clinical Biochemists 32, 177-195 (2011).
3. Crowley, E., Di Nicolantonio, F., Loupakis, F. & Bardelli, A. Liquid biopsy: monitoring cancer-genetics in the blood. Nature reviews. Clinical oncology 10, 472-484, doi: 10.1038/nrclinonc.2013.110 (2013).
4. Heitzer, E., Ulz, P. & Geigl, J. B. Circulating Tumor DNA as a Liquid Biopsy for Cancer. Clinical chemistry 61, 112-123, doi: 10.1373/ clinchem.2014.222679 (2015).
5. El-Naggar, A. K. et al. Genetic heterogeneity in saliva from patients with oral squamous carcinomas: implications in molecular diagnosis and screening. The Journal of molecular diagnostics: JMD 3, 164-170, doi: 10.1016/S1525-1578(10)60668-X (2001).
6. Couraud, S. et al. Noninvasive diagnosis of actionable mutations by deep sequencing of circulating free DNA in lung cancer from never-smokers: a proof-of-concept study from BioCAST/IFCT-1002. Clinical cancer research: an official journal of the American Association for Cancer Research 20, 4613-4624, doi: 10.1158/1078-0432.CCR-13-3063 (2014).
7. Chen, Z. et al. Enhanced sensitivity for detection of low-level germline mosaic RB1 mutations in sporadic retinoblastoma cases using deep semiconductor sequencing. Human mutation 35, 384-391, doi: 10.1002/humu.22488 (2014).
8. Bellini, A. et al. Deep Sequencing Reveals Occurrence of Subclonal ALK Mutations in Neuroblastoma at Diagnosis. Clinical cancer research: an official journal of the American Association for Cancer Research 21, 4913-4921, doi: 10.1158/1078-0432.CCR-15-0423 (2015).
9. DePristo, M. A. et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nature genetics 43, 491-498, doi: 10.1038/ng.806 (2011).
10. Schmitt, M. W. et al. Detection of ultra-rare mutations by next-generation sequencing. Proceedings of the National Academy of Sciences of the United States of America 109, 14508-14513, doi: 10.1073/pnas.1208715109 (2012).
11. Schmitt, M. W. et al. Sequencing small genomic targets with high efficiency and extreme accuracy. Nature methods 12, 423-425, doi: 10.1038/nmeth.3351 (2015).
12. Gregory, M. T. et al. Targeted single molecule mutation detection with massively parallel sequencing. Nucleic acids research 44, e22, doi: 10.1093/nar/gkv915 (2016).
13. Newman, A. M. et al. Integrated digital error suppression for improved detection of circulating tumor DNA. Nature biotechnology 34, 547-555, doi: 10.1038/nbt.3520 (2016).
14. Kivioja, T. et al. Counting absolute numbers of molecules using unique molecular identifiers. Nature methods 9, 72-74, doi: 10.1038/ nmeth.1778 (2012).
15. Kinde, I., Wu, J., Papadopoulos, N., Kinzler, K. W. & Vogelstein, B. Detection and quantification of rare mutations with massively parallel sequencing. Proceedings of the National Academy of Sciences of the United States of America 108, 9530-9535, doi: 10.1073/ pnas.1105422108 (2011).
16. Yamada, T. et al. Utility of KRAS mutation detection using circulating cell-free DNA from patients with colorectal cancer. Cancer science, doi: 10.1111/cas.12959 (2016).
17. Kuo, Y. B., Chen, J. S., Fan, C. W., Li, Y. S. & Chan, E. C. Comparison of KRAS mutation analysis of primary tumors and matched circulating cell-free DNA in plasmas of patients with colorectal cancer. Clinica chimica acta; international journal of clinical chemistry 433, 284-289, doi: 10.1016/j.cca.2014.03.024 (2014).
18. Cancer Genome Atlas, N. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330-337, doi: 10.1038/nature11252 (2012).
19. Newman, A. M. et al. An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage. Nat. Med. 20, 548-554 (2014).
20. Chen, G., Mosier, S., Gocke, C. D., Lin, M. T. & Eshleman, J. R. Cytosine deamination is a major cause of baseline noise in nextgeneration sequencing. Molecular diagnosis & therapy 18, 587-593, doi: 10.1007/s40291-014-0115-2 (2014).
21. Costello, M. et al. Discovery and characterization of artifactual mutations in deep coverage targeted capture sequencing data due to oxidative DNA damage during sample preparation. Nucleic acids research 41, e67, doi: 10.1093/nar/gks1443 (2013).
22. Lou, D. I. et al. High-throughput DNA sequencing errors are reduced by orders of magnitude using circle sequencing. Proceedings of the National Academy of Sciences of the United States of America 110, 19872-19877, doi: 10.1073/pnas.1319590110 (2013).
23. Sims, D., Sudbery, I., Ilott, N. E., Heger, A. & Ponting, C. P. Sequencing depth and coverage: key considerations in genomic analyses. Nature reviews. Genetics 15, 121-132, doi: 10.1038/nrg3642 (2014).
24. Kennedy, S. R. et al. Detecting ultralow-frequency mutations by Duplex Sequencing. Nature protocols 9, 2586-2606, doi: 10.1038/ nprot.2014.170 (2014).
25. Fromer, M. et al. Discovery and statistical genotyping of copy-number variation from whole-exome sequencing depth. American journal of human genetics 91, 597-607, doi: 10.1016/j.ajhg.2012.08.005 (2012).
26. Koressaar, T. & Remm, M. Enhancements and modifications of primer design program Primer3. Bioinformatics 23, 1289-1291, doi: 10.1093/bioinformatics/btm091 (2007).